No Data
No Data
No Data
No Data
No Data
Lineage Cell Therapeutics Inc May Offer And Sell Common Shares Of Up To $40M From Time To Time Through Or To B. Riley
Lineage Cell Therapeutics Inc May Offer And Sell Common Shares Of Up To $40M From Time To Time Through Or To B. Riley
BenzingaMar 23 04:36
Optimistic Buy Rating for Lineage Cell Therapeutics Ahead of OpRegen Study Data Release
TipRanksMar 19 13:46
15 Best Anti-Aging Foods for Youthful Skin
Yahoo FinanceMar 18 22:31
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium
Business WireMar 18 20:00
Billionaire Ken Fisher and Corporate Insiders Are Buying These 10 Stocks
Yahoo FinanceMar 15 03:53
RG6501 (OpRegen) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
Business WireMar 13 20:00
No Data
No Data